• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Final Research Report

Study on transmission of sporadic cerebral amyloid angiopathy

Research Project

  • PDF
Project/Area Number 15K15336
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Neurology
Research InstitutionKanazawa University

Principal Investigator

YAMADA Masahito  金沢大学, 医学系, 教授 (80191336)

Co-Investigator(Kenkyū-buntansha) 濱口 毅  金沢大学, 附属病院, 講師 (70452109)
Co-Investigator(Renkei-kenkyūsha) ONO Kenjiro  昭和大学, 医学部, 教授 (70377381)
SAKAI Kenji  金沢大学, 附属病院, 助教 (00572306)
Project Period (FY) 2015-04-01 – 2018-03-31
Keywords脳アミロイドアンギオパチー / アミロイドβ蛋白 / 伝播 / 剖検脳 / アルツハイマー病
Outline of Final Research Achievements

To examine a hypothesis that sporadic cerebral amyloid angiopathy (CAA) can be transmitted from humans to humans through CAA-specific amyloid β-protein (Aβ) strain, we performed transmission experiments to R1.40 APP transgenic mice with brain samples from patients with CAA without Alzheimer's disease (AD) (n = 3), AD with CAA (n = 3), AD without CAA (n = 3), and no AD/CAA (n = 3). Western blot of brains from the mice inoculated with the human brain samples presented with Aβ(n = 9)with Aβ40 (n = 3) or Aβ42 predominance (n = 6). Immunohistochemically, all the mice showed Aβ deposition in the brain with remarkable variations of Aβ42/Aβ40 ratios [Aβ42 immunoreactive areas (%)/Aβ40 immunoreactive areas (%)]. Severity of CAA correlated with Aβ40 immunoreactive areas (%). Study on correlations in the pattern of Aβ deposition between human and mouse brains is ongoing.

Free Research Field

神経内科学

URL: 

Published: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi